Abstract:OBJECTIVE:To study whether the expression level of cyclooxygenase-2 (COX-2) is correlated with the proliferation and apoptosis of cancer cells and to study whether the RNA interference technique can be used in anti-cancer gene therapy.METHODS:WBH1, a eukaryotic expression plasmid of shRNA targeting on COX-2, was constructed. Human gastric cancer cells of the line SGC-7901 were cultured and divided into 3 groups: to be transfected with WBH1 or negative control plasmid HK, or used as un-transfected control group. RT-PCR and Western blotting were used to detect the expression of COX-2 mRNA and protein. MTT method was used to detect the proliferation of the cells. The apoptosis of the cells was determined by flow cytometry. Fifteen nude mice were randomly divided into 3 equal groups: 10 to be inoculated subcutaneously with WBH1 plasmid transfected SGC-7901 cells (inhibition group) or negative control plasmid HK transfected SGC-7901 cells, and 5 were used as un-transfected controls. The mice were observed for 4 weeks to observe the survival and the tumorigenesis. Then the mice were killed to take out the tumors. The tumorigenic rate and tumor inhibition rate were evaluated.RESULTS:The proliferation of the SGC-7091 cells transfected with WHB1 plasmid did not changed significantly 24 and 48 hours after the transfection, however, decreased significantly 96 hours and 1 week after (both P < 0.01). The apoptotic rate of the SGC-7091 cells transfected with WHB1 plasmid was 52.28% +/- 17.91%, significantly higher than that of the cells transfected with the control plasmid HK (0.54% +/- 0.16%) and that of the un-transfected cells (0.52% +/- 0.27%, both P = 0.009) without a significant difference between the latter 2 groups (P = 0.998). Four weeks after inoculation the tumorigenic rate was 100% in both the un-transfected control mice and the mice inoculated with negative plasmid HK transfected SGC-7901 cells. There was no significant difference in tumor size between these 2 groups (P = 0.965). The tumorigenic rate of the mice in the inhibition group was 0.4 with an inhibition rate of 89.8%. The tumor weight of the inhibition group was 0.050 g +/- 0.003 g, significantly lighter than those of the control group and the group inoculated with negative plasmid transfected SGC cells (0.490 g +/- 0.017 g and 0.490 g +/- 0.013 g respectively, both P < 0.01).CONCLUSION:Construction of a eukaryotic expression vector expressing the specific shRNA targeting on COX-2, closely related to the proliferation and apoptosis of tumor cells, and transfection of it into the tumor cells helps inhibit the expression of COX-1, thus inhibiting the growth and proliferation of the tumor cells.

Functions Of The Ap-2 Alpha Gene In Activating Apoptosis And Inhibiting Proliferation Of Gastric Cancer Cells Both In Vitro And In Vivo

[Dual Role of Transcription Factor AP-2 in Carcinogenesis].

Down-Regulation Of Ap-4 Inhibits Proliferation, Induces Cell Cycle Arrest And Promotes Apoptosis In Human Gastric Cancer Cells

Astragalus Extract Inhibits Proliferation but Enhances Apoptosis in Gastric Cancer.

Reduced Expression of Transcription Factor AP-2α is Associated with Gastric Adenocarcinoma Prognosis.

Effect of Bone Morphogenetic Protein-2 on Proliferation and Apoptosis of Gastric Cancer Cells

AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway

Activator Protein-2β Promotes Tumor Growth and Predicts Poor Prognosis in Breast Cancer

Small Interfering RNA Inhibits Cell Proliferation in Gastric Cancer Cell Lines Highly Expressing RegIα

Overexpression of PrPC and Its Antiapoptosis Function in Gastric Cancer.

Ectopic Expression of AP-2α Transcription Factor Suppresses Glioma Progression.

Effect of angiopoietin-1 gene on the proliferation and apoptosis of human gastric cancer cells

Construction and Functional Verification of AP-2 Gene Family Eukaryotic Expression Vector

ApoG2 Induces ER Stress-Dependent Apoptosis in Gastric Cancer Cells in Vitro and Its Real-Time Evaluation by Bioluminescence Imaging in Vivo

Effects of gastrokine-2 expression on gastric cancer cell apoptosis by activation of extrinsic apoptotic pathways

Downregulation of Inhibitor of Apoptosis-Stimulating Protein of P53 Inhibits Proliferation and Promotes Apoptosis of Gastric Cancer Cells

Downregulation of XIAP Expression Induces Apoptosis and Enhances Chemotherapeutic Sensitivity in Human Gastric Cancer Cells

Hsa-miR-30a-3p attenuates gastric adenocarcinoma proliferation and metastasis via APBB2

Effects of Ppgalnact2 Antisense RNA on the Biological Behacior of Human Gastric Cancer SGC7901 Cell Line

[Effects of Inhibition of Cyclooxygenase-2 by RNA Interference on Proliferation and Apoptosis of Human Gastric Cancer Cells: an Experimental Study with Human Gastric Cancer Cells and Mice].

Abstract 2061: A Novel Small Molecule Inhibitor of MDM2-p53 (APG-115) Has Antitumor Activity in Gastric Adenocarcinoma